Memphasys receives early Thai FDA Felix approval
Memphasys' Felix System has received earlier than anticipated approval from the Thai Food and Drug Administration.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| KPT | Quarterly letter to shareholders | 24/04/18 | ||
| KPT | Corporate Governance Statement | 18/04/18 | ||
| KPT | Results of coastal process modelling | PRICE SENSITIVE | 16/04/18 | |
| KPT | Land shore and seabed tenure at Smith Bay | 09/03/18 | ||
| KPT | Land purchase at Smith Bay | PRICE SENSITIVE | 09/03/18 | |
| KPT | Subsidiary name change | 01/03/18 | ||
| KPT Quarterly letter to shareholders | |||
| 24/04/18 | |||
| KPT Corporate Governance Statement | |||
| 18/04/18 | |||
| KPT Results of coastal process modelling | |||
| 16/04/18 | PRICE SENSITIVE | ||
| KPT Land shore and seabed tenure at Smith Bay | |||
| 09/03/18 | |||
| KPT Land purchase at Smith Bay | |||
| 09/03/18 | PRICE SENSITIVE | ||
| KPT Subsidiary name change | |||
| 01/03/18 | |||
